Flow cytometry immunophenotyping in integrated diagnostics of patients with newly diagnosed cytopenia: one tube 10-color 14-antibody screening panel and 3-tube extensive panel for detection of MDS-related features

Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube

(2015) Amr Rajab et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes

(2014) Canan Alhan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Establishment of harmonization in immunophenotyping: A comparative study of a standardized one-tube lymphocyte-screening panel

(2014) F. W. M. B. Preijers et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes

(2014) Canan Alhan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

(2014) A Porwit et al.   LEUKEMIA

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

(2013) M. Dreyling et al.   ANNALS OF ONCOLOGY

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

(2013) L. Malcovati et al.   BLOOD

Bone marrow evaluation in new-onset pancytopenia

(2013) Elizabeth P. Weinzierl et al.   HUMAN PATHOLOGY

Immunophenotyping of selected hematologic disorders - focus on lymphoproliferative disorders with more than one malignant cell population

(2013) A. Porwit   International Journal of Laboratory Hematology

The Differential Diagnosis and Bone Marrow Evaluation of New-Onset Pancytopenia

(2012) Elizabeth P. Weinzierl et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

(2012) M. Ghielmini et al.   ANNALS OF ONCOLOGY

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

(2012) M. G. Della Porta et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

(2012) T M Westers et al.   LEUKEMIA

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

(2012) J J M van Dongen et al.   LEUKEMIA

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

(2012) Arjan A. van de Loosdrecht et al.   LEUKEMIA & LYMPHOMA

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10

(2011) M C Béné et al.   LEUKEMIA

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study

(2009) K. Ogata et al.   HAEMATOLOGICA

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

(2009) A. A. van de Loosdrecht et al.   HAEMATOLOGICA

Flow cytometric immunophenotyping for hematologic neoplasms

(2008) F. E. Craig et al.   BLOOD